EYPT
EyePointยทNASDAQ
--
--(--)
--
--(--)
EYPT Profile
Eyepoint, Inc.
A pharmaceutical company that focused on ophthalmic treatments
480 Pleasant Street, Watertown, MA 02472
--
EyePoint, Inc., incorporated in Delaware on March 19, 2008, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to help improve the lives of patients with severe retinal diseases. The Company utilizes its proprietary biodegradable Durasert E technology for continuous intraocular drug delivery, addressing the challenges posed by frequent intravitreal injections. Its lead product candidate, DURAVYU, is an investigational therapy for the treatment of vascular endothelial growth factor-mediated retinal diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
